Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyGraft SurvivalCyclophosphamideTissue DonorsHematopoietic Stem CellsBusulfanMyeloablative AgonistsMultiple MyelomaTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesAmyloidosisHematopoiesisLeukemiaSalvage TherapyIfosfamideSurvival RateSurvival AnalysisVincristineBlood CellsCarmustineGraft vs Leukemia EffectCytarabineHodgkin DiseaseTime FactorsLeukemia, Myeloid, AcuteBlood DonorsPlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticLiver TransplantationBlood Cell CountLymphomaCytophagocytosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionNeoplasmsFatal OutcomeFollow-Up StudiesFeasibility StudiesHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsHematologic DiseasesHLA AntigensCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaDoxorubicinBone MarrowImmunophenotypingImmunosuppressionProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinKidney TransplantationBone Marrow DiseasesAntigens, CDPrognosisBlood Group IncompatibilityTransplantation ImmunologyCell Transplantation